Laboratory Automation Market Research Report Forecast to 2030
상품코드:1465626
리서치사:Market Research Future
발행일:2024년 04월
페이지 정보:영문 281 Pages
라이선스 & 가격 (부가세 별도)
한글목차
실험실 자동화 시장 규모는 예측 기간 동안 8.15%의 CAGR로 성장할 것으로 예상됩니다.
생명공학 기업과 제약회사들은 증가하는 의료 수요에 대응하기 위해 R&D에 큰 관심을 기울이고 있으며, R&D 활동에 대한 관심의 확대는 임상 실험실 자동화 시스템 및 소프트웨어에 대한 수요를 창출하고 있습니다. 실험실 자동화는 임상 실험실 작업 프로세스의 생산성을 향상시키고, 비용 절감과 처리량 확대를 통해 더 나은 ROI를 가져오고 더 많은 생명을 구할 수 있습니다.
또한, 실험실은 새로운 장비와 소프트웨어 등 새로운 기술 혁신을 지속적으로 도입하고 있습니다. 실험실 자동화는 하드웨어와 로봇을 기계화하는 프로그래밍을 사용하여 인간의 감시가 거의 필요 없는 기계화 프로그래밍을 포함합니다. 실험실 자동화는 환자가 더 나은 치료를 더 빨리 받을 수 있도록 도울 수 있습니다.
세계 실험실 자동화 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 시장 규모 추정 및 예측, 각 부문별·지역별 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
제2장 시장 개요
제3장 조사 방법
제4장 시장 역학
개요
성장 촉진요인
R&D 활동에 대한 투자 증가
실험실 자동화 시스템 도입 증가
성장 억제요인
실험실 인프라 자동화의 높은 초기 자본 투자액
기회
신흥 국가의 헬스케어 인프라 개선
제5장 시장 요인 분석
밸류체인 분석
Porter's Five Forces 분석
COVID-19가 실험실 자동화 시장에 미치는 영향
제6장 세계의 실험실 자동화 시장 : 제품 유형별
개요
자동화 워크스테이션
자동 액체 처리
마이크로플레이트 리더
자동 ELISA 시스템
자동 핵산 정제 시스템
로봇 시스템
소프트웨어 및 인포매틱스
전자연구노트
워크스테이션/유닛 자동화 소프트웨어
과학 데이터 관리 시스템
실험실 정보 관리 시스템
기타
제7장 세계의 실험실 자동화 시장 : 프로세스별
개요
연속 플로우
워크플로우
컴포넌트
디스크리트 처리
방법
컴포넌트
워크플로우
제8장 세계의 실험실 자동화 시장 : 용도별
개요
임상 진단
유전체학 솔루션
단백질체학 솔루션
Drug Discovery
기타
제9장 세계의 실험실 자동화 시장 : 최종사용자별
개요
바이오테크놀러지 및 제약 기업
병원 및 진단 실험실
연구·학술기관
제10장 세계의 실험실 자동화 시장 : 지역별
개요
북미
유럽
아시아태평양
라틴아메리카, 중동 및 아프리카
제11장 경쟁 상황
개요
경쟁 벤치마킹
주요 성장 전략
개발 건수로 상위 기업
주요 개발 분석
주요 전개와 성장 전략
재무 매트릭스
제12장 기업 개요
THERMO FISHER SCIENTIFIC INC.
AGILENT TECHNOLOGIES INC.
TECAN TRADING AG
BIOMERIEUX SA
SIEMENS HEALTHINEER
BECKMAN COULTER, INC.
QIAGEN N.V.
PERKINELMER INC.
HAMILTON COMPANY
F. HOFFMANN-LA ROCHE LTD
제13장 부록
ksm
영문 목차
영문목차
Market Overview
Laboratory Automation Market is anticipated to register a CAGR of 8.15% during the forecast period. There are various variables driving the market development. The most conspicuous market impetuses incorporate the rising Research and development ventures and rising reception of laboratory automation frameworks.
Biotechnology and drug organizations are making huge interests in Research and development to meet the developing necessities of medical care. Expanding interests in Research and development exercises have encouraged an interest in laboratory automation frameworks and programming. Laboratory automation helps increment the productivity of the clinical laboratory's work process, bringing about a better yield on speculation (return for money invested) through decreased costs and expanded throughput, which further can possibly save lives.
In addition, labs are continually embracing innovation, including new gear, and programming. Laboratory automation includes using programming that mechanizes hardware and robots to work with insignificant human oversight, which further develops effectiveness and the nature of results. Automation in the laboratory can assist patients with getting better treatment more rapidly.
Market Segmentation
The Laboratory Automation Market segmentation, based on product type, includes automated workstations, robotic systems, software & informatics, and others. Automated workstation is further divided into automated liquid handling, microplate readers, automated Elisa systems, and automated nucleic acid purification systems. Software & informatics is segmented into electronic laboratory notebook, workstation/unit automation software, scientific data management system, and laboratory information management system.
Based on process, the market is classified into continuous flow and discrete processing. Discrete processing is further divided into the method, components, and workflow. The method type is further bifurcated into discrete centrifugal and random-access discrete processing.
Based on application the market is classified into clinical diagnostics, genomics solutions, proteomics solutions, drug discovery, and others. Based on end user, the Laboratory Automation Market is segmented into biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and research & academic institutes.
Regional Insights
North America is credited to the rising interest in drug disclosure, rigid FDA guidelines, and the presence of enormous drug organizations, like Johnson and Johnson (US), Pfizer Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Merck and Co., Inc. (US), and others.
Europe Laboratory Automation Market represents the second-biggest market share because of deep rooted medical services foundation in nations like Germany, France, the UK, and others, which has prompted an expansion in the reception of advanced mechanics and laboratory automation frameworks in the locale.
The Asia-Pacific laboratory automation market is supposed to develop at a huge offer from 2022 to 2030. This is because of the elements like further developing medical care framework, an ascent in the quantity of drug organizations, and a flood in mindfulness about cutting edge laboratory automation frameworks supporting the market development.
Major Players
Key Companies in the Laboratory Automation Market are Beckman Coulter, Inc. (US), QIAGEN N.V. (Germany), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Tecan Trading AG (Switzerland), BioMerieux SA (France), Siemens Healthineer (Germany), PerkinElmer Inc. (US), Hamilton Company (US), and Hoffmann-La Roche Ltd (Switzerland).
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING INVESTMENT IN R&D ACTIVITIES
4.2.2 RISING ADOPTION OF LABORATORY AUTOMATION SYSTEMS
4.3 RESTRAINTS
4.3.1 HIGH INITIAL CAPITAL INVESTMENTS IN AUTOMATING LABORATORY INFRASTRUCTURE
4.4 OPPORTUNITIES
4.4.1 IMPROVING HEALTHCARE INFRASTRUCTURE ACROSS EMERGING COUNTRIES
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 ENGAGEMENT & DESIGNING
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES FOLLOW-UPS
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE LABORATORY AUTOMATION MARKET
5.3.1 OVERVIEW
5.3.2 IMPACT ON COST OF RAW MATERIALS
5.3.3 IMPACT ON AVAILABILITY OF PRODUCTS
5.3.4 IMPACT ON TRADE (IMPORT/EXPORT)
6 GLOBAL LABORATORY AUTOMATION MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 AUTOMATED WORKSTATIONS
6.2.1 AUTOMATED LIQUID HANDLING
6.2.1.1 AUTOMATED INTEGRATED WORKSTATIONS
6.2.1.2 PIPETTING SYSTEMS
6.2.1.3 REAGENT DISPENSERS
6.2.1.4 MICROPLATE WASHERS
6.2.2 MICROPLATE READERS
6.2.2.1 MULTI-MODE MICROPLATE READERS
6.2.2.2 SINGLE-MODE MICROPLATE READERS
6.2.3 AUTOMATED ELISA SYSTEMS
6.2.4 AUTOMATED NUCLEIC ACID PURIFICATION SYSTEMS
6.3 ROBOTIC SYSTEMS
6.4 SOFTWARE & INFORMATICS
6.4.1 ELECTRONIC LABORATORY NOTEBOOK
6.4.2 WORKSTATION/UNIT AUTOMATION SOFTWARE
6.4.3 SCIENTIFIC DATA MANAGEMENT SYSTEM
6.4.4 LABORATORY INFORMATION MANAGEMENT SYSTEM
6.5 OTHERS
7 GLOBAL LABORATORY AUTOMATION MARKET, BY PROCESS
7.1 OVERVIEW
7.2 CONTINUOUS FLOW
7.2.1 WORKFLOW
7.2.1.1 SEQUENTIAL PROCESSING
7.2.1.2 PARALLEL PROCESSING
7.2.2 COMPONENTS
7.2.2.1 CONSUMABLES
7.2.2.2 EQUIPMENT
7.3 DISCRETE PROCESSING
7.3.1 METHOD
7.3.1.1 CENTRIFUGAL DISCRETE PROCESSING
7.3.1.2 RANDOM ACCESS DISCRETE PROCESSING
7.3.2 COMPONENTS
7.3.2.1 CONSUMABLES
7.3.2.2 EQUIPMENT
7.3.3 WORKFLOW
7.3.3.1 DEPENDENT ANALYSIS
7.3.3.2 INDEPENDENT ANALYSIS
8 GLOBAL LABORATORY AUTOMATION MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 CLINICAL DIAGNOSTICS
8.3 GENOMICS SOLUTIONS
8.4 PROTEOMICS SOLUTIONS
8.5 DRUG DISCOVERY
8.6 OTHERS
9 GLOBAL LABORATORY AUTOMATION MARKET, BY END USER
9.1 OVERVIEW
9.2 BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES
9.3 HOSPITALS & DIAGNOSTIC LABORATORIES
9.4 RESEARCH & ACADEMIC INSTITUTES
10 GLOBAL LABORATORY AUTOMATION MARKET, BY REGION
10.1 OVERVIEW
10.2 NORTH AMERICA
10.2.1 US
10.2.2 CANADA
10.2.3 MEXICO
10.3 EUROPE
10.3.1 GERMANY
10.3.2 FRANCE
10.3.3 UK
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 NETHERLANDS
10.3.7 SWEDEN
10.3.8 RUSSIA
10.3.9 POLAND
10.3.10 AUSTRIA
10.3.11 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 AUSTRALIA
10.4.5 SOUTH KOREA
10.4.6 TAIWAN
10.4.7 SINGAPORE
10.4.8 MALAYSIA
10.4.9 THAILAND
10.4.10 REST OF ASIA-PACIFIC
10.5 LAMEA
10.5.1 SOUTH AFRICA
10.5.2 SAUDI ARABIA
10.5.3 UNITED ARAB EMIRATES
10.5.4 EGYPT
10.5.5 REST OF LAMEA
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 COMPETITIVE BENCHMARKING
11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL LABORATORY AUTOMATION MARKET
11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL LABORATORY AUTOMATION MARKET
